COMPANY

Contego Medical

Keywords: peripheral vascular disease

Location: Raleigh, NC · source · Oct 14, 2026

Profile checked Oct 10, 2026

Timeline

Jun 13, 2025 FDA FDA 510(k) clearance: Excipio LV Prime Thrombectomy Device — K251485, Jun 13, 2025. Applicant at approval: Contego Medical, Inc. source ↗
Oct 11, 2024 FDA FDA PMA approval: Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection — P240009, Oct 11, 2024. Applicant at approval: Contego Medical, Inc. source ↗

Jun 13, 2025 FDA 510(k) clearance: Excipio LV Prime Thrombectomy Device — K251485, Jun 13, 2025. Applicant at approval: Contego Medical, Inc. source ↗
Oct 11, 2024 FDA PMA approval: Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection — P240009, Oct 11, 2024. Applicant at approval: Contego Medical, Inc. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12